Renalytix Plc
RENX.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | £3,000 | £2,289 | £3,403 | £2,970 |
| % Growth | 31.1% | -32.7% | 14.6% | – |
| Cost of Goods Sold | £1,800 | £2,133 | £2,702 | £2,052 |
| Gross Profit | £1,200 | £156 | £701 | £918 |
| % Margin | 40% | 6.8% | 20.6% | 30.9% |
| R&D Expenses | £900 | £9,390 | £14,298 | £14,648 |
| G&A Expenses | £4,900 | £19,751 | £43,056 | £12,951 |
| SG&A Expenses | £5,300 | £19,751 | £28,662 | £12,951 |
| Sales & Mktg Exp. | £400 | £0 | £0 | £0 |
| Other Operating Expenses | £12,200 | £623 | £96 | £30,691 |
| Operating Expenses | £18,400 | £29,764 | £43,056 | £58,290 |
| Operating Income | -£17,200 | -£29,608 | -£42,355 | -£53,183 |
| % Margin | -573.3% | -1,293.5% | -1,244.6% | -1,790.7% |
| Other Income/Exp. Net | -£4,600 | -£3,844 | -£3,384 | £7,932 |
| Pre-Tax Income | -£21,800 | -£33,452 | -£45,605 | -£45,251 |
| Tax Expense | -£1,400 | £4 | £2 | £25 |
| Net Income | -£20,400 | -£33,456 | -£45,607 | -£45,276 |
| % Margin | -680% | -1,461.6% | -1,340.2% | -1,524.4% |
| EPS | -0.21 | -0.31 | -0.55 | -0.62 |
| % Growth | 32.3% | 43.6% | 11.3% | – |
| EPS Diluted | -0.21 | -0.31 | -0.55 | -0.67 |
| Weighted Avg Shares Out | 97,270 | 108,179 | 82,210 | 67,982 |
| Weighted Avg Shares Out Dil | 97,270 | 108,179 | 82,210 | 73,837 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £509 | £12 |
| Interest Expense | £500 | £0 | £0 | £2 |
| Depreciation & Amortization | £0 | £364 | £508 | £489 |
| EBITDA | -£21,300 | -£28,521 | -£41,713 | -£52,694 |
| % Margin | -710% | -1,246% | -1,225.8% | -1,774.2% |